In response to the rising incidence of indolent, low-risk prostate cancer (PCa) due to
increased prostate-specific antigen (PSA) screening in the 1990s, active surveillance (AS) …

Context The clinical effectiveness of focal therapy (FT) for localised prostate cancer (PCa)
remains controversial. Objective To analyse the evidence base for primary FT for localised …

Background Although the use of multiparametric magnetic resonance imaging (mpMRI) in
active surveillance (AS) for prostate cancer is of increasing interest, existing data are derived …

Hyperpolarised magnetic resonance imaging (HP 13C-MRI) is an emerging clinical
technique to detect [1-13C] lactate production in prostate cancer (PCa) following intravenous …

Serial MRI is an essential assessment tool in prostate cancer (PCa) patients enrolled on
active surveillance (AS). However, it has only moderate sensitivity for predicting …

Background Active surveillance (AS) protocols rely on rectal examination, prostate-specific
antigen, imaging, and biopsy to identify disease progression. Objective To evaluate whether …

Objectives To compare the performance of the PRECISE scoring system against several
MRI-derived delta-radiomics models for predicting histopathological prostate cancer (PCa) …

Many men diagnosed with localized prostate cancer can postpone definitive treatment
without raising their risk of metastasis or death from disease. Active surveillance (AS) is a …

The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation
(PRECISE) recommendations were published in 2016 to standardize the reporting of MRI …

Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active
surveillance (AS) as their initial management strategy. While this may reduce the side effects …